Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572251 | 12757225 | 1 | I | 20040723 | 20150326 | 20160919 | 20160919 | EXP | FR-ROCHE-1557049 | ROCHE | 0.00 | F | Y | 0.00000 | 20160919 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572251 | 12757225 | 1 | PS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 1 | G | SOLUTION FOR INFUSION | |||||||
| 127572251 | 12757225 | 2 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 1 | G | SOLUTION FOR INFUSION | |||||||
| 127572251 | 12757225 | 3 | SS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 1 | G | SOLUTION FOR INFUSION | |||||||
| 127572251 | 12757225 | 4 | SS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 127572251 | 12757225 | 5 | C | CORTANCYL | PREDNISONE | 1 | 0 | ||||||||||||
| 127572251 | 12757225 | 6 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 0 | 100 | MG | |||||||||
| 127572251 | 12757225 | 7 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127572251 | 12757225 | 8 | C | HUMIRA | ADALIMUMAB | 1 | 0 | ||||||||||||
| 127572251 | 12757225 | 9 | C | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | 0 | |||||||||||
| 127572251 | 12757225 | 10 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 0 | |||||||||||
| 127572251 | 12757225 | 11 | C | SALAZOPYRINE | SULFASALAZINE | 1 | Unknown | 0 | |||||||||||
| 127572251 | 12757225 | 12 | C | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | |||||||||||
| 127572251 | 12757225 | 13 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127572251 | 12757225 | 1 | Rheumatoid arthritis |
| 127572251 | 12757225 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127572251 | 12757225 | HO |
| 127572251 | 12757225 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127572251 | 12757225 | Cataract | |
| 127572251 | 12757225 | Cholecystitis acute | |
| 127572251 | 12757225 | Diabetes mellitus | |
| 127572251 | 12757225 | Drug intolerance | |
| 127572251 | 12757225 | Embolism | |
| 127572251 | 12757225 | Herpes zoster | |
| 127572251 | 12757225 | Infusion related reaction | |
| 127572251 | 12757225 | Invasive ductal breast carcinoma | |
| 127572251 | 12757225 | Medical device site abscess | |
| 127572251 | 12757225 | Nasal herpes | |
| 127572251 | 12757225 | Osteoporotic fracture | |
| 127572251 | 12757225 | Sleep disorder | |
| 127572251 | 12757225 | Thyroid cyst | |
| 127572251 | 12757225 | Tibia fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127572251 | 12757225 | 1 | 20040723 | 0 | ||
| 127572251 | 12757225 | 2 | 20040806 | 0 | ||
| 127572251 | 12757225 | 3 | 20050110 | 0 | ||
| 127572251 | 12757225 | 4 | 20091209 | 0 | ||
| 127572251 | 12757225 | 9 | 20050512 | 0 | ||
| 127572251 | 12757225 | 10 | 20061005 | 0 | ||
| 127572251 | 12757225 | 11 | 20080430 | 0 | ||
| 127572251 | 12757225 | 12 | 20081211 | 0 | ||
| 127572251 | 12757225 | 13 | 20090324 | 0 |